Abstract:Background: The use of povidone-iodine for ocular surface asepsis is widespread for intravitreal injections. They became frequent procedures, leading to serial exposure of patients' eyes to iodinated solutions. In this study, we investigate the changes in the ocular surface in patients submitted to repeated use of povidine for intravitreal injection of anti-VEGF asepsis, analyzing Ocular Surface Disease Index, non-invasive break up time, blinking quality, lipid layer, meniscus height and osmolarity. Methods: This case-control study included 34 individuals (68 eyes), 14 males, 20 females aged 48 to 94. Inclusion criteria were individuals who received application of 2% povidone-iodine eyedrops for intravitreal injections treatment with the non-treated contralateral eye used as control. Ocular surface examinations were performed at a single occasion. A pre-intravitreal injection asepsis protocol with povidone-iodine was applied. All statistical analysis was performed using the STATA® 18.0 Software and a p-value = 0.05 was considered as the statistical significance value in all tests. Results: The median number of IVIs in treated eyes was 12 (range 6-20). The results in treated eyes compared with untreated eyes were respectively : median OSDI 16 (IQR 6-39) and 12.5 (IQR 8-39) (p = 0.380); mean NIBUT 10.30 (SD ± 2.62) and 10.78 (SD ± 2.92) ( s, p = 0.476); median blinking quality 100 (IQR 100) and 100 (IQR 100 ) (%, p = 0.188); median lipid layer 87 (IQR 77-90) and 86 (IQR 74-100) (nm, p = 0.451); median meniscus height 0.22 (IQR 0.19-0,31) and 0.24 (IQR 0.20-0.27) (mm, p = 0.862), median Meibomian gland atrophy 33 (IQR 24-45) and 31.5 (IQR 25-39) (%, p = 0.524); and mean osmolarity 306.6 (SD ± 21.13) and 313.8 (SD ± 29) (mOsm, p = 0.297). There was no statistically significant relationship between the repetitive use of 2% iodinated solution and signs or symptoms compatible with dry eye syndrome in this group of patients. Conclusions: The findings suggest that 2% povidone iodine is a safe and efficacious agent for ocular surface antisepsis during intravitreal injections, not leading to substantial ocular surface modifications. This conclusion supports the continued use of povidone iodine in routine ophthalmic procedures without increased risk of inducing dry eye syndrome.

Effect of Domestic Povidone Iodine on Conjunctival Sac Disinfection

Rinsing the Conjunctival Sac with Povidone-Iodine Solution Before Cataract Surgery: A Meta-Analysis

Effectiveness of 1.25 % povidone-iodine combined with topical levofloxacin against conjunctival flora in intravitreal injection

Comparison of iodine compounds and levofloxacin as postoperative instillation; conjunctival bacterial flora and antimicrobial susceptibility following cataract surgery

In vivo assessment of antimicrobial activity and toxicity of repeated 1% povidone-iodine applications versus a single 5% povidone-iodine application

The effect of recurrent povidone-iodine usage on conjunctival flora in diabetic patients undergoing intravitreal injections

Rates of endophthalmitis before and after transition from povidone-iodine to aqueous chlorhexidine asepsis for intravitreal injection

Topical antiseptics in minimizing ocular surface bacterial load before ophthalmic surgery: a randomized controlled trial

Effect comparison of different skin preparations before intraocular surgery

Culture positivity and distribution of the conjunctival sac bacteria in the perioperative period of corneal refractive surgery

Inhibitory Effect of Short-Term Palpebral Margin Cleaning with Antibiotic Eye Drops on Ocular Surface Flora Before Cataract Extraction: A New Preoperative Antibacterial Method

The Effect of Oral Mucosal Disinfection with Povidone-Iodine in Oral and Maxillofacial Surgery

Analysis of Bacterial Culture of Conjunctiva Sac Before Intraocular Surgery

Comparison of preoperative prophylaxis with povidone–iodine (5%) and moxifloxacin (0.5%) versus povidone–iodine (5%) alone: a prospective study from India

Analysis of the pollution of aqueous humor in intraocular lens implantation in the treatment of cataract and countermeasures

Clinical Study about Bacteria Contamination of Aqueous Humor During Cataract Operation

Povidone-iodine in vitro antiseptic efficacy as a function of exposure duration, concentration, preparation, and length of storage

Povidone-iodine: an anti-oedematous agent?

Using 2% PVPI topical solution for serial intravitreous injections and ocular surface findings: a case control study

Low-concentration Povidone-iodine and Normal Saline as Irrigant on Reducing Postoperative Complications after the Third-molar Surgery: A Comparative Study

Effect of low-concentration povidone iodine on postoperative complications after third molar surgery: a pilot split-mouth study